Genpact LTD current report, 18 March 2010

Business Context and Reporting Period

This Form 8-K Current Report was filed by Genpact Limited on March 18, 2010. The filing discloses a significant corporate event involving a public offering of common shares by certain selling shareholders, rather than a routine financial reporting period.

Key Financial Metrics

The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity for the company. The primary financial data point relates to the equity transaction:

  • Shares Sold: 33,600,000 Genpact common shares.
  • Option Exercised: An additional 5,040,000 shares were purchased by underwriters exercising a 30-day option on March 19, 2010.
  • Total Shares: 38,640,000 shares involved in the transaction.
  • Proceeds to Company: Genpact will not receive any proceeds from this offering.

Material Changes

The material change reported is the execution of an underwriting agreement on March 18, 2010, between Genpact and selling shareholders (affiliates of General Electric Company, General Atlantic LLC, Oak Hill Capital Partners, and Wells Fargo & Company). The transaction represents a secondary offering where existing shareholders are selling their holdings to the public. The offering, including the option shares, was expected to close on March 24, 2010.

Guidance, Outlook, and Risks

The filing contains no management guidance, financial outlook, or discussion of operational risks. The primary contingency noted is that the closing of the offering is subject to customary closing conditions. The document references an opinion of legality issued by Appleby, Bermuda counsel, regarding the shares to be sold.

Investor Verification Checklist

  • Verify the final closing date of the offering (expected March 24, 2010) and the actual public offering price per share.
  • Confirm the post-offering ownership percentages of the Selling Shareholders (GE, General Atlantic, Oak Hill, Wells Fargo) to assess remaining control.
  • Review the full Underwriting Agreement (Exhibit 1.1) for details on underwriting discounts and commissions.
  • Check subsequent filings for any changes in Genpact's capital structure resulting from this secondary offering.